Trintellix and Cellcept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trintellix (vortioxetine hydrobromide) and Cellcept (mycophenolate mofetil). Common drug interactions include skin infection among females and aphonia among males.

The phase IV clinical study analyzes what interactions people have when they take Trintellix and Cellcept. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Trintellix?

Trintellix has active ingredients of vortioxetine hydrobromide. It is often used in depression. eHealthMe is studying from 13,067 Trintellix users. Check the latest studies of Trintellix.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.



On Jul, 05, 2026

21 people who take Trintellix and Cellcept together, and have interactions are studied.

Trintellix and Cellcept drug interactions.

What are the common drug interactions of Trintellix and Cellcept, by gender? *:

female:

  1. Skin infection
  2. Infusion site haematoma (localized swelling filled with blood at infusion site)
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Weight increased
  6. Sinusitis (inflammation of sinus)
  7. Abdominal pain upper
  8. Cerebral disorder (brain disease)
  9. Cystitis (inflammation of the wall of the bladder)
  10. Haematoma (collection of blood outside the blood vessels)

male:

  1. Aphonia (inability to produce voice)
  2. Cough
  3. Dizziness
  4. Dyspnoea (difficult or laboured respiration)
  5. Productive cough
  6. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the common drug interactions of Trintellix and Cellcept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Weight increased
  2. Sinusitis (inflammation of sinus)
  3. Cystitis (inflammation of the wall of the bladder)
  4. Haematoma (collection of blood outside the blood vessels)
  5. Psoriasis (immune-mediated disease that affects the skin)
  6. Abdominal pain upper
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Constipation
  9. Flatulence (flatus expelled through the anus)
  10. Kidney infection

50-59:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Herpes zoster
  3. Oral herpes (viral infection of mouth)

60+:

n/a

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 10 people, 47.62%
  2. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Trintellix and Cellcept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Trintellix and Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trintellix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trintellix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cellcept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vortioxetine hydrobromide and mycophenolate mofetil (the active ingredients of Trintellix and Cellcept, respectively), and Trintellix and Cellcept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: